Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2020
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detectionNora Isberner, Fatemeh Aghai, Diana Schirmer, et al.Analytical and Bioanalytical Chemistry|November 6, 2020
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasmaFatemeh Aghai, Sebastian Zimmermann, Max Kurlbaum, et al.Cancer Chemotherapy and Pharmacology|September 10, 2021
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trialNora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit, et al.Pharmaceutics|December 23, 2022
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease PatientsBettina Gerner, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.Clinical Biochemistry|April 28, 2022
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoringFatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Anja Gesierich, et al.Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.Journal of Pharmaceutical and Biomedical Analysis|February 25, 2023
Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinibSebastian Zimmermann, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.Pageof 1